Login to Your Account

Other news to note

Thursday, January 9, 2014

Biolinerx Ltd., of Jerusalem, signed a collaboration agreement with JHL Biotech, of Hsinchu, Taiwan, to develop and commercialize BL-9020 for Type I diabetes.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription